Histone-Lysine N-Methyltransferase MLL4 (MLL4) (N-Term) Peptide
Quick Overview for Histone-Lysine N-Methyltransferase MLL4 (MLL4) (N-Term) Peptide (ABIN8102627)
Target
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- MLL4 Peptide - N-terminal region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-MLL4 antibody ( ARP33704_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- MLL4 (Histone-Lysine N-Methyltransferase MLL4 (MLL4))
-
Background
-
Background Information: MLL4 a protein which contains multiple domains including a CXXC zinc finger, three PHD zinc fingers, two FY-rich domains, and a SET (suppressor of variegation, enhancer of zeste, and trithorax) domain. The SET domain is a conserved C-terminal domain that characterizes proteins of the MLL (mixed-lineage leukemia) family. MLL4 is ubiquitously expressed in adult tissues. It is also amplified in solid tumor cell lines, and may be involved in human cancer
Alternative Symbols: HRX2, MLL2, TRX2, WBP7, MLL4
-
Molecular Weight
- 64kDa
-
Gene ID
- 9757
-
UniProt
- Q9UMN6
Target
-